- The recent evolution of anesthesia strategy
- The future of medical-dental integration is here
- Trinity Health to open $226M replacement hospital April 19
- Sharp HealthCare taps Apple Vision Pro for surgical innovation
- The law that could help fix anesthesia reimbursement issues — and why it’s being ignored
- UW Health inks deal to become Packers’ official healthcare partner
- California hospital CEO steps down
- How CHS, HCA, Tenet, and UHS’ CEO-to-worker pay ratios ranked in 2025
- Texas dentist has license suspended
- RFK Jr. says he’ll reform preventive task force: 4 hearing takeaways
- 10 fastest-growing jobs for new graduates
- Northwestern Medicine posts 4.5% operating margin in Q2
- Rotavirus cases increase across US
- Tenet’s 5 highest-paid execs in 2025
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- Stereotaxis to acquire cardiovascular robotics company for $45M
- Meritus Health adds Dr. Christine Lewis
- What’s the deal with insurer mental health parity violations?
- NYU Langone Health opens 12K-square-foot ambulatory location
- 10 anesthesia leadership appointments from Q1
- What could improve physician market competition
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- How ESOPs can help retiring physicians cash out
- Specialty1 Partners’ growth in 2026: 5 updates
- UnityPoint Health to transition dental services to FQHC
- The ownership opportunity ASCs are leaving behind
- New York hospital taps ambulatory operations leader
- 10 trends in behavioral health usage: Report
- 4 DSOs adding new technology
- Aspen Dental opens Michigan office
- Studies reaffirm fluoride safety, benefits: 10 things to know
- New Oklahoma law closes dental insurer price fixing loophole
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- Kentucky approves changes to Dental Practice Act
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- EPA Delays Decisions on 'Forever Chemicals'
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- ‘Mini specialists’: 5 models reshaping behavioral health in primary care
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Progyny unveils new fertility benefit option for small, mid-size employers
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Chicago hospital expands outpatient, walk-in mental health services
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Bill would force payers to apply DTC drug purchases to patient deductibles
- 43 states have mental health insurance disparities: 4 trends
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- The new playbook for clinician well-being
- Listen to the Latest ‘KFF Health News Minute’
- Estados cambian leyes para evitar que hijos de inmigrantes detenidos entren al sistema de cuidado temporal
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- Cómo hacer que un plan de salud con deducible alto funcione para tí
- Anthem, Mount Sinai reach contract agreement, restore in-network coverage
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Stanford Health Care, Alameda Health System partner to support St. Rose Hospital
- Para muchos pacientes que salen de terapia intensiva, la lucha apenas comienza
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Marriage's Hidden Benefit? A Lower Risk Of Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Los estados se enfrentan a otro reto con las nuevas reglas laborales de Medicaid: la falta de personal
- States Change Custody Laws To Keep Children of Detained Immigrants Out of Foster Care
- WebMD Ignite rolls out program to help providers get Rural Health Transformation efforts off the ground
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- NewYork-Presbyterian to enact behavioral health reforms, pay $500K in wake of investigation
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Wavelet Medical, Aegis Ventures partner on first AI non-invasive fetal EEG monitoring platform
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- New Rules May Allow Broader Picks for CDC Vaccine Panel
- Second Meningitis Vaccine Doses Offered After U.K. Outbreak
- Crackdown on Vapes Falling Short, Report Finds
- Jasmine Rice Recalled Nationwide Over Possible Contamination
- ‘The next opioid epidemic’: Gambling legalization outpaces public health response to addiction
- Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare
- Fighting High Blood Pressure? Having A Team On Your Side Can Help
- Radon Gas Increases Risk Of Ovarian Cancer, Study Says
- Your Doctor Might Be Using The Wrong Test To Track Your Cholesterol, Study Says
- Losing Teeth May Lead to Weight Gain, Researchers Report
- Heart Risk Worse With Sleep Apnea That Varies Night-By-Night
- Lilly’s Jaypirca shows fixed-duration power in ‘ambitious’ phase 3 CLL trial win
- ViiV launches ‘Still Here’ campaign aimed at reminding young people about HIV
- Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
- Statement Regarding Staff No-Action Letter to Bank of England
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- The Healthcare Burnout Backlash (pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
- BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
The once and future President Trump has nominated Dr. Martin Adel Makary to head the Food and Drug Administration. Stanley Goldfarb, an emeritus professor of medicine at the University of Pennsylvania, has just posted a review of Dr. Makary's latest book: Blind Spots:When Medicine Gets It Wrong, and What It Means for Our Health. The review gives you some insight into Dr. Makary's thoughts on health care in America:
https://freebeacon.com/culture/in-search-of-a-second-opinion/
In Search of a Second Opinion
REVIEW: ‘Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health’ by Marty Makary
By Stanley Goldfarb - November 24, 2024When patients turn to professional societies like the AMA or the American College of Physicians or the American Association of Pediatrics for vital health information, one might expect that the information is based on publications in prestigious medical journals of carefully designed and meticulously interpreted studies. Dr. Marty Makary, in his book Blind Spots, shows how wrong these assumptions can be.
Makary is a frequent commentator on health-related topics. He is a surgeon and surgical oncologist at Johns Hopkins Hospital. Blind Spots consists of several examples where the medical establishment has perpetuated a myth often based on a single academic’s opinion that became ingrained in the culture as "truth" despite the flimsiest of evidence. Using examples like avoiding exposure to peanuts in infants, producing an epidemic of peanut allergy, or denying the benefits of hormone replacement therapy in perimenopausal women, resulting in premature deaths and suboptimal health outcomes, Makary proves his case against groupthink in medicine. He goes on to rail against the overuse of antibiotics because of their potential for altering the microbial composition in the GI tract. Recent research shows that this effect of antibiotics may contribute to serious complications, including risks for cancer and cardiovascular disease.
Another section recounts the saga of the treatment of ulcers of the upper GI tract. Ulcer disease was treated as a neuropsychiatric disorder that required behavioral modification and buffering stomach acid to prevent recurrences. The evidence that a particular bacterium caused stomach ulcers was known for several years, but the medical establishment resisted this insight simply because it flew against conventional wisdom. Eventually, Dr. Barry Marshall won the Nobel Prize in medicine for the discovery. He had to induce his own ulcer disease by ingesting the bacteria that he identified to finally convince the skeptics.
Makary also visits the controversy about so-called gender-affirming care for children. This treatment involves drugs that prevent children with confusion about their sexuality from experiencing a normal puberty, administers sex characteristic-altering hormones, and even life-altering surgical procedures like mastectomies. He quotes some of the most thoughtful critics of these procedures, such as Lisa Littman, who first identified the phenomenon of the rapid onset of gender dysphoria when teenage girls first encounter the earliest phases of puberty. Despite overwhelming evidence that she was correct in her idea that these children had a temporary form of juvenile angst, she was effectively "canceled" because the concept undermined the theory of an underlying biological basis for the psychological disorder.
Gender-affirming care is yet another idea that falls into the category of dangerous treatments accepted by the medical establishment despite ongoing proof that it harms many children. Sadly, almost every major American medical society supports gender-affirming care for these troubled children, while several European nations have examined their own experience with this therapy and the published medical evidence with an open mind and now severely restrict its implementation.
Readers will find this book interesting if they have not had much of a background in biomedical science. It is clear, concise, and well-documented. They may ask a few more questions at their yearly checkup, and that is a good thing.
Why do these wrongheaded approaches to medical care exist, and what can be done to prevent their perpetuation? Makary describes the phenomenon of maintaining a closed mind in the face of contravening data but never quite gets to the originating cause of this attitude in the medical establishment. He does make a strong case for the benefit of classical liberal principles, such as freedom of speech and willingness to confront hierarchies as antidotes. But at a time when conformity and groupthink seem to have taken hold of the most recent generations of physicians, Makary nonetheless praises the current young generation as including vigorous disruptors who will challenge the medical status quo. But has he watched the cult-like recitations of new medical students at their white coat ceremonies about land acknowledgments to indigenous people and obeisance to the oppressor/oppressed paradigm of "systemic racism"? They don’t seem likely to challenge anything.
The unwillingness to have an open mind when examining controversial topics or confronting new information suggests a deeper problem. The problem is, in large part, the culture of medical education. More and more, physicians are taught and regurgitate the "facts." Medicine has increasingly focused on doing rather than knowing. The monetary rewards are skewed toward performing procedures and tests. Understanding basic disease mechanisms or evaluating the quality of medical studies are less valued. This is not a new problem, and Makary cites examples of physicians ignoring best practices or new knowledge in favor of traditional approaches going back centuries. It is easy to understand how this attitude predominated in the era when medical science was primitive, and all that existed was opinion. But modern medical science allows physicians to approach clinical problems with a deep understanding of the mechanisms of disease and underlying biomedical science. Despite this, the failure to improve the closed-mindedness is ongoing. The problem has become more acute given the recent trend in training medical students to be social justice warriors rather than rigorous clinical scientists.
Medical students now learn almost exclusively through taking practice exams and studying the answers to the multiple-choice questions that make up the exams. It is virtually unheard of for students to be assigned textbooks or even specific articles in the medical literature and then asked to interpret the information. They chafe when presented with basic science information if its clinical relevance is not immediately obvious. Yet such knowledge is crucial to good medicine.
To develop independent thinking among physicians, the medical curriculum should develop critical thinking skills about biomedical topics, and students recruited to become physicians should be those who embrace such an approach. Instead, students are increasingly chosen based on their agreement with theories of "systemic racism" and "social determinants of health" rather than their potential to become clinical scientists.
Makary believes that among the current crop of trainees are those who will disrupt the modes of thinking that produce the wrongheaded outcomes he describes. I fear he is wrong in his prescription. I think a more active intervention is needed. Undergraduate and graduate medical education need a reform agenda. Deep learning on experimental design, data interpretation, critical reading of the medical literature, and understanding the philosophy of science should replace the many hours currently spent trying to turn young physicians into social workers.
Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health
by Marty Makary
Bloomsbury Publishing, 288 pp., $28.99
Stanley Goldfarb is an emeritus professor of medicine at the University of Pennsylvania and father of Washington Free Beacon chairman Michael Goldfarb.
In short - med students need training in how to think, instead of what to think.
I couldn't agree more! Cookie-cutter medicine is letting patients everywhere fall through the cracks.
Another fascinating take on Dr. Makary comes from his previous employer and my frequent source in this Forum for Healthcare Headlines.
https://www.medpagetoday.com/washington-watch/fdageneral/113078
Trump's FDA Pick Is MedPage Today's Former Top Editor
— Marty Makary has made a name for himself challenging the medical establishment
President-elect Donald Trump has chosen Marty Makary, MD, MPH, to run the FDA.
Makary served as the editor-in-chief of MedPage Today from January 2020 through the end of 2021.
"FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator. The Agency needs Dr. Marty Makary, a Highly Respected Johns Hopkins Surgical Oncologist and Health Policy Expert, to course-correct and refocus the Agency," Trump said on Friday, in announcing the nomination on Truth Social.
"He will work under the leadership of Robert F. Kennedy Jr. to, among other things, properly evaluate harmful chemicals poisoning our Nation's food supply and drugs and biologics being given to our Nation's youth, so that we can finally address the Childhood Chronic Disease Epidemic," Trump added.
Trump also announced the nominations of Dave Weldon, MD, for CDC Director and Janette Nesheiwat, MD, for U.S. Surgeon General.
Makary has written three books on medicine and healthcare: Blind Spots, The Price We Pay, and Unaccountable, the last of which was turned into a TV series called "The Resident." A theme of all three books is challenging the status quo in medicine, questioning the evidence base for certain treatments and established clinical practices. Among his top issues, Makary has taken on the high costs of healthcare and medicine's penchant for overtreatment. He also authored Mama Maggie, a book about a woman who aids the poor people of Egypt's slums.
Early in the COVID-19 pandemic, Makary espoused some views that were in opposition to mainstream medicine, including championing the power of natural immunity, challenging vaccine mandates, and questioning the need for COVID vaccines in children. Makary famously predicted in February 2021 that the U.S. would have "herd immunity by April" 2021.
In 2023, Makary testified before Congress that a lab leak origin of SARS-CoV-2 from the Wuhan Institute of Virology in China was a "no-brainer."
More recently, he has reverted to speaking out against the core business-of-healthcare issues that initially sparked his rise to fame, including how hospitals that make profits should pay taxes, and exposing how certain Medicare policies enable hospital and health system monopolies.
Makary completed his surgical residency at Georgetown University Hospital in Washington, D.C., after attending medical school at Thomas Jefferson University in Philadelphia. He received his Master of Public Health degree from Harvard University. In 2018 he was elected to the National Academy of Medicine.
At FDA, Makary would be in charge of the agency's annual budget of $7 billion, and he would report to Kennedy, Trump's pick for HHS secretary, if confirmed by the Senate.
Late last month, Kennedy lashed out at the FDA in a post on X: "FDA's war on public health is about to end. This includes its aggressive suppression of psychedelics, peptides, stem cells, raw milk, hyperbaric therapies, chelating compounds, ivermectin, hydroxychloroquine, vitamins, clean foods, sunshine, exercise, nutraceuticals, and anything else that advances human health and can't be patented by Pharma. If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags."
Outgoing FDA Commissioner Robert Califf, MD, has fought against medical misinformation, and pushed for improvements in food safety and inspections. He recently said that under a Trump administration, FDA's ability to hire and retain skilled employees could be in jeopardy, given Kennedy's hostility to civil servants.
Dr. Martin Adel Makary is now the Commissioner of the Food and Drug Administration:
https://thehill.com/homenews/administration/5214293-senate-confirms-marty-makary-fda/
Senate confirms Marty Makary to lead FDA
By Nathaniel Weixel - March 25, 2025The Senate on Tuesday night confirmed Marty Makary to be the Food and Drug Administration commissioner.
Makary was easily confirmed by a 56-44 vote, picking up three Democrats.
Democratic Sens. Dick Durbin (Ill.) Maggie Hassan (N.H.) and Jeanne Shaheen (N.H.) voted with all Republicans to confirm Makary.
A Johns Hopkins surgeon, Makary will take over an agency hammered by workforce cuts imposed by Elon Musk’s Department of Government Efficiency.
He will also have to navigate politically tricky decisions on access to the abortion medication mifepristone, as well as about vaccine policy under Health and Human Services Secretary Robert F. Kennedy Jr, a prominent vaccine skeptic.
Democrats hammered Makary during his confirmation hearing on recent moves by the Trump administration to cut FDA staff and pressed him on plans to exercise his authority over mifepristone.
GOP senators urged him to curb access, while Democrats pressed him to keep the current policies in place.
Makary tread carefully in his responses, saying he had no preconceived notions about the drugs and would “take a solid, hard look at the data” about mifepristone’s safety.
Makary was a critic of federal COVID-19 mitigation policies and frequently appeared on Fox News during the pandemic.
Makary during his hearing largely said he supported the benefits of vaccines, even as he was being pressed about the recent cancellation of agency advisory panels.
“Vaccines save lives, and I do believe that any child who dies of a vaccine-preventable illness is a tragedy in the modern era,” he said.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















